News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
SBLENDORIO GLENN
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/13/2023 |
4
| SBLENDORIO GLENN (CEO) has filed a Form 4 on IVERIC bio, Inc.|
Txns:
| Disposed/sold 239,275 shares
@ $0
Disposed/sold 23,750 restricted stock units
@ $0
Disposed/sold 73,315 restricted stock units
@ $0
Disposed/sold 94,500 restricted stock units
@ $0
Disposed/sold 150,000 restricted stock units
@ $0
Disposed/sold 6,949 options to buy
@ $33.27, valued at
$231.2k
Disposed/sold 15,000 options to buy
@ $37, valued at
$555k
Disposed/sold 7,000 options to buy
@ $48.3, valued at
$338.1k
Disposed/sold 150,000 options to buy
@ $44.9, valued at
$6.7M
Disposed/sold 260,000 options to buy
@ $4.52, valued at
$1.2M
Disposed/sold 325,000 options to buy
@ $2.94, valued at
$955.5k
|
|
| 06/12/2023 |
4
| SBLENDORIO GLENN (Director) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Granted 8,584 shares
@ $0
Granted 30,474 options to buy
@ $12.62, valued at
$384.6k
|
|
| 05/25/2023 |
4
| SBLENDORIO GLENN (Director) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Granted 8,111 shares
@ $0
Granted 12,547 options to buy
@ $9.17, valued at
$115.1k
|
|
| 05/19/2023 |
4
| SBLENDORIO GLENN (Director) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Exercised 15,000 options to buy
@ $3.32, valued at
$49.8k
|
|
| 01/04/2023 |
4
| SBLENDORIO GLENN (CEO) has filed a Form 4 on IVERIC bio, Inc.|
Txns:
| Sold 17,447 shares
@ $20.06, valued at
$350k
Exercised 31,500 restricted stock units
@ $0 |
|
| 12/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/22/2022 |
4
| SBLENDORIO GLENN (CEO) has filed a Form 4 on IVERIC bio, Inc.|
Txns:
| Granted 300,000 options to buy
@ $22.57, valued at
$6.8M
Granted 150,000 restricted stock units
@ $0 |
|
| 12/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2022 |
4
| SBLENDORIO GLENN (Director) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Granted 7,737 shares
@ $0
Granted 12,790 options to buy
@ $16.82, valued at
$215.1k
|
|
| 04/06/2022 |
4
| SBLENDORIO GLENN (CEO) has filed a Form 4 on IVERIC bio, Inc.|
Txns:
| Sold 50,000 shares
@ $18.7561, valued at
$937.8k
|
|
| 04/01/2022 |
4
| SBLENDORIO GLENN (CEO) has filed a Form 4 on IVERIC bio, Inc.|
Txns:
| Sold 1,213 shares
@ $17.004, valued at
$20.6k
Sold 1,400 shares
@ $17.02, valued at
$23.8k
Sold 40,756 shares
@ $17.5, valued at
$713.2k
Exercised 1,213 options to buy
@ $2.94, valued at
$3.6k
Exercised 1,400 options to buy
@ $2.94, valued at
$4.1k
Exercised 40,756 options to buy
@ $2.94, valued at
$119.8k
|
|
| 03/29/2022 |
4
| SBLENDORIO GLENN (CEO) has filed a Form 4 on IVERIC bio, Inc.|
Txns:
| Sold 18,775 shares
@ $17.06, valued at
$320.3k
Exercised 18,775 options to buy
@ $2.94, valued at
$55.2k
|
|
| 03/22/2022 |
4
| SBLENDORIO GLENN (CEO) has filed a Form 4 on IVERIC bio, Inc.|
Txns:
| Sold 3,479 shares
@ $17.0006, valued at
$59.1k
Exercised 3,479 options to buy
@ $2.94, valued at
$10.2k
|
|
| 03/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/03/2022 |
4
| SBLENDORIO GLENN (CEO) has filed a Form 4 on IVERIC bio, Inc.|
Txns:
| Sold 100 shares
@ $17.01, valued at
$1.7k
Sold 801 shares
@ $17.005, valued at
$13.6k
Exercised 100 options to buy
@ $2.94, valued at
$294
Exercised 801 options to buy
@ $2.94, valued at
$2.4k
|
|
| 12/27/2021 |
4
| SBLENDORIO GLENN (CEO) has filed a Form 4 on IVERIC bio, Inc.|
Txns:
| Sold 22,163 shares
@ $16.5042, valued at
$365.8k
Sold 31,084 shares
@ $16.9584, valued at
$527.1k
Gifted 20,000 shares
@ $0
Sold 5,229 shares
@ $16.636, valued at
$87k
Exercised 22,163 options to buy
@ $1.45, valued at
$32.1k
Exercised 22,608 options to buy
@ $1.45, valued at
$32.8k
Exercised 8,476 options to buy
@ $2.94, valued at
$24.9k
Exercised 5,229 options to buy
@ $1.45, valued at
$7.6k
|
|
| 12/21/2021 |
4
| SBLENDORIO GLENN (CEO) has filed a Form 4 on IVERIC bio, Inc.|
Txns:
| Sold 18,524 shares
@ $15.4435, valued at
$286.1k
Exercised 36,658 restricted stock units
@ $0 |
|
| 12/20/2021 |
4
| SBLENDORIO GLENN (CEO) has filed a Form 4 on IVERIC bio, Inc.|
Txns:
| Granted 252,000 options to buy
@ $14.83, valued at
$3.7M
Granted 126,000 restricted stock units
@ $0 |
|
| 12/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2021 |
4
| SBLENDORIO GLENN (Director) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Granted 7,029 shares
@ $0
Granted 12,089 options to buy
@ $17.08, valued at
$206.5k
|
|
| 12/22/2020 |
4
| SBLENDORIO GLENN (President & CEO) has filed a Form 4 on IVERIC bio, Inc.|
Txns:
| Granted 293,130 options to buy
@ $7.5, valued at
$2.2M
Granted 146,630 restricted stock units
@ $0 |
|
| 12/15/2020 |
4
| SBLENDORIO GLENN (President and CEO) has filed a Form 4 on IVERIC bio, Inc.|
Txns:
| Exercised 22,950 restricted stock units
@ $0 |
|
| 12/11/2020 |
4
| SBLENDORIO GLENN (President and CEO) has filed a Form 4 on IVERIC bio, Inc.|
Txns:
| Exercised 23,750 restricted stock units
@ $0 |
|
| 06/08/2020 |
4
| SBLENDORIO GLENN (Director) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Granted 5,855 shares
@ $0
Granted 18,574 options to buy
@ $12.81, valued at
$237.9k
|
|
| 06/01/2020 |
4
| SBLENDORIO GLENN (Director) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Granted 1,595 shares
@ $0
Granted 2,966 options to buy
@ $72.74, valued at
$215.7k
|
|
| 04/03/2020 |
4
| SBLENDORIO GLENN (President and CEO) has filed a Form 4 on IVERIC bio, Inc.|
Txns:
| Exercised 18,750 restricted stock units
@ $0 |
|
| 12/16/2019 |
4
| SBLENDORIO GLENN (President and CEO) has filed a Form 4 on IVERIC bio, Inc.|
Txns:
| Exercised 22,950 restricted stock units
@ $0 |
|
| 12/11/2019 |
4
| SBLENDORIO GLENN (President and CEO) has filed a Form 4 on IVERIC bio, Inc.|
Txns:
| Bought 62,500 shares
@ $4, valued at
$250k
Granted 190,000 options to buy
@ $5.22, valued at
$991.8k
Granted 95,000 restricted stock units
@ $0 |
|
| 11/18/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|